Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MEMANT-3310 by Antabio for Acinetobacter Infections: Likelihood of Approval
MEMANT-3310 is under clinical development by Antabio and currently in Phase I for Acinetobacter Infections. According to GlobalData, Phase I...